Search Results 1291-1300 of 10491 for cannabis
This is a Phase 3, randomized, double-blind, placebo-controlled study evaluating the clinical benefit and safety of EFX in subjects with compensated cirrhosis ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
BT – L-CsA – 301 – SLT: A Phase III, Prospective, Multicenter, Randomized, Controlled Clinical Trial To Demonstrate The Efficacy And Safety Of Liposomal ...
About this study. The primary objective of this study is to investigate the safety, tolerability, and effectiveness of multiple doses of LP352 in adult ...
Read about brain cancer research at Mayo Clinic. Explore Mayo Clinic. Request an appointment. Mayo Clinic Q and A: Treatment with medical cannabis.
There aren't any posts to show yet. About the News Network · Newsbureau@mayo.edu · News Releases · Cancer · Cardiovascular · Gastroenterology ...
This phase II trial studies how well midostaurin and decitabine work in treating older patients with newly diagnosed acute myeloid leukemia and fms-related ...
Learn which medicines are more likely to cause an allergic reaction, what symptoms look like and what treatments can calm such a reaction.
Nonalcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease in the world and a major public health issue in the US. It is ...
Payne CS, et al Cannabis and male fertility. Journal of Urology. 2019; doi:10.1097/JU.0000000000000248. Lo JO, et al. Impact of cannabinoids on pregnancy ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.